Hepion Pharmaceuticals, Inc.(HEPA)
Health Care Services
Lab Testing & Diagnostics
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-04-21 | Purcell Michael J. Director | Purchase | +1,250,000 | +100.00%1,250,000 | $0.04 | $50,000 | View SEC filing | |
| 2026-04-21 | LoPriore Vincent S Executive Chairman | Purchase | +6,250,000 | +125.00%11,250,000 | $0.04 | $250,000 | View SEC filing | |
| 2026-04-21 | Appajosyula Sireesh Director | Purchase | +1,250,000 | +100.00%1,250,000 | $0.04 | $50,000 | View SEC filing | |
| 2026-04-21 | Stetz Gary S. Interim CEO | Purchase | +1,250,000 | +100.00%1,250,000 | $0.04 | $50,000 | View SEC filing | |
| 2023-11-28 | Wijngaard Peter Director | Purchase | +5,000 | +111.09%9,501 | $3.07 | $15,350 | View SEC filing | |
| 2023-09-20 | Wijngaard Peter Director | Purchase | +3,000 | +199.87%4,501 | $5.61 | $16,841 | View SEC filing | |
| 2023-09-19 | Foster Robert T CEO and Director | Purchase | +1,600 | +3.27%50,470 | $5.60 | $8,960 | View SEC filing | |
| 2023-09-18 | Foster Robert T CEO,CSO and Director | Purchase | +1,600 | +3.38%48,870 | $5.40 | $8,640 | View SEC filing | |
| 2021-02-18 | Wijngaard Peter Director | Purchase | +10,000 | +50.00%30,000 | $2.20 | $22,000 | View SEC filing | |
| 2021-02-18 | Foster Robert T CEO and Director | Purchase | +20,000 | +79.18%45,259 | $2.00 | $40,000 | View SEC filing | |
| 2021-02-18 | Cavan John T Chief Financial Officer | Purchase | +10,000 | +208.33%14,800 | $2.00 | $20,000 | View SEC filing | |
| 2020-12-21 | Wijngaard Peter Director | Purchase | +20,000 | +100.00%20,000 | $1.91 | $38,200 | View SEC filing | |
| 2020-12-08 | Foster Robert T CEO and Director | Purchase | +25,000 | +9652.51%25,259 | $1.58 | $39,418 | View SEC filing | |
| 2020-12-02 | BRANCACCIO JOHN P Director | Purchase | +7,000 | +87500.00%7,008 | $1.53 | $10,710 | View SEC filing | |
| 2020-12-01 | JACOB GARY S Director | Purchase | +12,000 | +20338.98%12,059 | $1.66 | $19,920 | View SEC filing | |
| 2020-11-30 | Cavan John T Chief Financial Officer | Purchase | +4,500 | +1500.00%4,800 | $1.62 | $7,290 | View SEC filing | |
| 2018-07-03 | JACOB GARY S Director | Purchase | +18,303 | +100.00%18,303 | $472.05 | $8,640,000 | View SEC filing | |
| 2018-07-03 | Cavan John T CFO | Purchase | +18,303 | +100.00%18,303 | $472.05 | $8,640,000 | View SEC filing | |
| 2018-07-03 | Lippa Arnold Director | Purchase | +18,303 | +100.00%18,303 | $472.05 | $8,640,000 | View SEC filing | |
| 2018-07-03 | BRANCACCIO JOHN P Director | Purchase | +3,661 | +100.00%3,661 | $472.00 | $1,728,000 | View SEC filing | |
| 2017-06-22 | Cavan John T CFO | Purchase | +20,000 | +100.00%20,000 | $0.65 | $13,000 | View SEC filing | |
| 2016-02-18 | SAPIRSTEIN JAMES Chief Executive Officer | Purchase | +10,000 | +333.33%13,000 | $1.00 | $10,000 | View SEC filing | |
| 2015-12-01 | SAPIRSTEIN JAMES Chief Executive Officer | Purchase | +500 | +20.00%3,000 | $2.15 | $1,075 | View SEC filing | |
| 2015-11-24 | SAPIRSTEIN JAMES Chief Executive Officer | Purchase | +2,500 | +100.00%2,500 | $1.64 | $4,100 | View SEC filing | |
| 2014-03-07 | BRANCACCIO JOHN P Director | Purchase | +4,393 | +218.01%6,408 | $1.49 | $6,546 | View SEC filing |
1-25 of 25